Denmark’s Leo Pharma Forms Collaboration With Berlin’s Charité University Hospitals
This article was originally published in The Pink Sheet Daily
Denmark’s dermatology-focused Leo Pharma sets up the first of a series of long-term collaborations with clinical researchers to boost its R&D pipeline.
You may also be interested in...
Leo Pharma Aims To Extend Reach Of Dermatology Business With Global Expansion And Picato’s Green Light For Europe
Danish dermatology specialist Leo Pharma is hunting for new pipeline assets after its next major product – Picato gel – got the green light from Europe’s top regulator.
The collaboration is the third in its localized Centers for Therapeutic Innovation project, intended to nudge academics toward commercial projects.
Acquisition more than doubles GSK’s dermatology sales to $1.5 billion, creating a global specialist business across prescription and OTC drugs.